Corrigendum: Girdin maintains the stemness of glioblastoma stem cells (Oncogene (2012) 31 (2715-2724) DOI: 10.1038/onc.2011.466);Girdin maintains the stemness of glioblastoma stem cells

Oncogene

Volumn 31, Issue 22, 2012, Pages 2715-2724

  Natsume, A ^a   Kato, T ^a   Kinjo, S ^a   Enomoto, A ^a   Toda, H ^a   Shimato, S ^a   Ohka, F ^a   Motomura, K ^a   Kondo, Y ^b   Miyata, T ^a   Takahashi, M ^a   Wakabayashi, T ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

Cancer stem cells; Girdin; Glioblastoma; Migration; Stemness

Indexed keywords

ACTIN BINDING PROTEIN; BETA TUBULIN; CD33 ANTIGEN; CELL MARKER; GIRDIN; GLIAL FIBRILLARY ACIDIC PROTEIN; NESTIN; PROTEIN KINASE B; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CANCER INVASION; CANCER STEM CELL; CARCINOGENESIS; CELL DIFFERENTIATION; CELL ISOLATION; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; EX VIVO STUDY; FEMALE; GENE SILENCING; GLIOBLASTOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NERVE CELL DIFFERENTIATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN STABILITY;

EID: 84860529052     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2017.17     Document Type: Erratum

References (28)

1. Anai M, Shojima N, Katagiri H, Ogihara T, Sakoda H, Onishi Y et al. (2005). A novel protein kinase B (PKB)/AKT-binding protein enhances PKB kinase activity and regulates DNA synthesis. J Biol Chem 280: 18525-18535. (Pubitemid 41389103)
2. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB et al. (2006). Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444: 756-760. (Pubitemid 44949604)
3. Brazil DP, Park J, Hemmings BA. (2002). PKB binding proteins. Getting in on the Akt. Cell 111: 293-303. (Pubitemid 35341386)
4. Castellino RC, Durden DL. (2007). Mechanisms of disease: the PI3KAkt-PTEN signaling node-an intercept point for the control of angiogenesis in brain tumors. Nat Clin Pract Neurol 3: 682-693. (Pubitemid 350238060)
5. Datta SR, Brunet A, Greenberg ME. (1999). Cellular survival: a play in three Akts. Genes Dev 13: 2905-2927.
6. Enomoto A, Asai N, Namba T, Wang Y, Kato T, TanakaMet al. (2009). Roles of disrupted-in-schizophrenia 1-interacting protein girdin in postnatal development of the dentate gyrus. Neuron 63: 774-787.
7. Enomoto A, Murakami H, Asai N, Morone N, Watanabe T, Kawai K et al. (2005). Akt/PKB regulates actin organization and cell motility via Girdin/APE. Dev Cell 9: 389-402. (Pubitemid 41235808)
8. Eyler CE, Foo WC, LaFiura KM, McLendon RE, Hjelmeland AB, Rich JN. (2008). Brain cancer stem cells display preferential sensitivity to Akt inhibition. Stem Cells 26: 3027-3036.
9. Gunther HS, Schmidt NO, Phillips HS, Kemming D, Kharbanda S, Soriano R et al. (2008). Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria. Oncogene 27: 2897-2909. (Pubitemid 351620450)
10. Hay N. (2005). The Akt-mTOR tango and its relevance to cancer. Cancer Cell 8: 179-183. (Pubitemid 41317589)
11. Hemmati HD, Nakano I, Lazareff JA, Masterman-Smith M, Geschwind DH, Bronner-Fraser M et al. (2003). Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci USA 100: 15178-15183. (Pubitemid 37518036)
12. Hennessy BT, Smith DL, Ram PT, Lu Y, Mills GB. (2005). Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat Rev Drug Discov 4: 988-1004.
13. Hermann PC, Huber SL, Herrler T, Aicher A, Ellwart JW, Guba M et al. (2007). Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1: 313-323. (Pubitemid 47355323)
14. Jiang P, Enomoto A, Jijiwa M, Kato T, Hasegawa T, Ishida M et al. (2008). An actin-binding protein Girdin regulates the motility of breast cancer cells. Cancer Res 68: 1310-1318. (Pubitemid 351346837)
15. Kato H, Ishida J, Nagano K, Honjo K, Sugaya T, Takeda N et al. (2008). Deterioration of atherosclerosis in mice lacking angiotensin II type 1A receptor in bone marrow-derived cells. Lab Invest 88: 731-739. (Pubitemid 351896638)
16. Kim JY, Duan X, Liu CY, Jang MH, Guo JU, Pow-anpongkul N et al. (2009). DISC1 regulates new neuron development in the adult brain via modulation of AKT-mTOR signaling through KIAA1212. Neuron 63: 761-773.
17. Kitamura T, Asai N, Enomoto A, Maeda K, Kato T, Ishida M et al. (2008). Regulation of VEGF-mediated angiogenesis by the Akt/PKB substrate Girdin. Nat Cell Biol 10: 329-337. (Pubitemid 351331020)
18. Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, Donin NM et al. (2006). Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 9: 391-403. (Pubitemid 43668737)
19. Luo J, Manning BD, Cantley LC. (2003). Targeting the PI3K-Akt pathway in human cancer: rationale and promise. Cancer Cell 4: 257-262. (Pubitemid 37329790)
20. Matsumoto K, Arao T, Tanaka K, Kaneda H, Kudo K, Fujita Y et al. (2009). mTOR signal and hypoxia-inducible factor-1 alpha regulate CD133 expression in cancer cells. Cancer Res 69: 7160-7164.
21. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T et al. (2004). Identification of human brain tumour initiating cells. Nature 432: 396-401. (Pubitemid 39551674)
22. Soeda A, Park M, Lee D, Mintz A, Androutsellis-Theotokis A, McKay RD et al. (2009). Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha. Oncogene 28: 3949-3959.
23. Sonoda Y, Ozawa T, Aldape KD, Deen DF, Berger MS, Pieper RO. (2001). Akt pathway activation converts anaplastic astrocytoma to glioblastoma multiforme in a human astrocyte model of glioma. Cancer Res 61: 6674-6678. (Pubitemid 32896484)
24. Vivanco I, Sawyers CL. (2002). The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer 2: 489-501. (Pubitemid 37328931)
25. Wakimoto H, Kesari S, Farrell CJ, Curry Jr WT, Zaupa C, Aghi M et al. (2009). Human glioblastoma-derived cancer stem cells: establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors. Cancer Res 69: 3472-3481.
26. Wendel HG, De Stanchina E, Fridman JS, Malina A, Ray S, Kogan S et al. (2004). Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy. Nature 428: 332-337. (Pubitemid 38418805)
27. Yuki K, Natsume A, Yokoyama H, Kondo Y, Ohno M, Kato T et al. (2009). Induction of oligodendrogenesis in glioblastoma-initiating cells by IFN-mediated activation of STAT3 signaling. Cancer Lett 284: 71-79.
28. Zhang B, Gu F, She C, Guo H, Li W, Niu R et al. (2009). Reduction of Akt2 inhibits migration and invasion of glioma cells. Int J Cancer 125: 585-595.